NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK's Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy

Stock Information for NantKwest Inc.

Loading

Please wait while we load your information from QuoteMedia.